Corton Capital’s Solid Biosciences SLDB Stock Holding History

Corton Capital’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,152	Closed	-$40.6K	–	389
2024 Q4	$40.6K	Buy	+10,152	New	+$55.8K	0.02%	368

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Corton Capital's SLDB Position: Q1 2025 in Review

Corton Capital sold out of Solid Biosciences (SLDB) in Q1 2025, closing a stake of 10,152 shares — an estimated $40.6K sold.

Corton Capital first reported a position in SLDB in Q4 2024 and held it in 1 quarter. The position peaked at $40.6K in Q4 2024. 124 funds tracked by Wall St. Rank hold SLDB as of Q1 2025.

Corton Capital reported no remaining Solid Biosciences position as of Q1 2025 after selling out during the quarter.
Corton Capital sold 10,152 Solid Biosciences shares in Q1 2025, an estimated $40.6K.
Corton Capital first reported a position in Solid Biosciences in Q4 2024 and held it in 1 quarter.
Corton Capital's Solid Biosciences position peaked at $40.6K in Q4 2024.
124 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.